SP
Starpharma Holdings Limited
SPL.AX · ASX
$0.82 +1.23% (+$0.01)
1M +1.89%
Market Cap $341.0M
P/E Ratio -
Div. Yield -
ROE 38.57%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 28.29x
P/B 24.75x
P/E N/A
Growth
78 /100
Growing Rev. growth 60.05%
Book val. growth 26.58%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 86.26%
Net margin 61.95%
Op. margin 159.60%
Quality
8 /100
Poor ROIC 52.98%
ROE 38.57%
ROA 39.25%
Debt
100 /100
Low Debt/Equity 0.05x
Current ratio 3.40x
Int. coverage N/A
Stability
43 /100
Moderate Beta 0.76x
Rev. volatility 119.44%
EPS volatility 35.36%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SPL.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheryl Maley
Employees
50
Headquarters
Abbotsford
Prihajajoči dogodki
02 MAR.
Earnings
Upcoming earnings report